Ensoma Announces $85 Million Financing and Agreement to Acquire Twelve Bio to Advance Portfolio of In Vivo Engineered Cellular Medicines

Some of the best links we picked up around the internet

Italian scientists have demonstrated the potential of a targeted CRISPR-Cas9 delivery system to suppress tumour growth and metastasis in prostate...

A study by researchers at Tel Aviv University introduces new predictive features based on codon usage bias (CUB) and gene expression that...

Researchers used large language models (LLMs) to expand the sequence diversity of CRISPR-Cas proteins and generate novel, functional genome editors...

Some of the best links we picked up around the internet

A CRISPR-based screen has revealed that the transcription factor ZNF740 plays a pivotal role in determining the sensitivity of acute myeloid leukaemia...